Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01433471 · ClinicalTrials.gov registry record · NA
Mucosal Immunity of Ulcerative Colitis Patients Undergoing Therapy With Trichuris Suis Ova
A NA study, sponsored by NYU Langone Health.
- Completed
- Registry status
- NA
- Development phase
- 4
- Enrollment target
NCT01433471 is a NA study that has completed, run by NYU Langone Health. The registered enrollment target is 4 participants.
The verdict
NCT01433471, a NA study, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 4 participants
- Enrollment target
Study Summary
The purpose of this study is to understand the immune response activated in the human gastrointestinal tract by Trichuris Suis Ova (TSO) in patients with ulcerative colitis.
Interventions
- DRUG Trichuris suis ova
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2012-08 |
| Est. Completion | 2015-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01433471
The ClinicalTrials.gov registry entry for NCT01433471 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Trichuris suis ova is the first listed.
NCT01433471 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01433471 about?
NCT01433471 is a clinical study titled "Mucosal Immunity of Ulcerative Colitis Patients Undergoing Therapy With Trichuris Suis Ova". The purpose of this study is to understand the immune response activated in the human gastrointestinal tract by Trichuris Suis Ova (TSO) in patients with ulcerative colitis.
What is the current status of trial NCT01433471?
This trial is currently completed. It is a NA study. The enrollment target is 4 participants. The study started on 2012-08. Estimated completion is 2015-05.
What interventions are being tested in trial NCT01433471?
The interventions under investigation include: Trichuris suis ova (DRUG).
Who is sponsoring clinical trial NCT01433471?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.